Dr Robert G Durrans, MD | |
501 E 770 N, Orem, UT 84097-4102 | |
(801) 724-9840 | |
(801) 235-1509 |
Full Name | Dr Robert G Durrans |
---|---|
Gender | Male |
Speciality | Family Medicine |
Location | 501 E 770 N, Orem, Utah |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1447332465 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 93225397-1205 (Utah) | Primary |
207Q00000X | Family Medicine | 93225397 (Utah) | Secondary |
Entity Name | Mountain Peaks Family Practice, Lc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023263969 PECOS PAC ID: 7012071442 Enrollment ID: O20090130000240 |
News Archive
Many women are not screened for chlamydia and gonorrhea infection during their pregnancy, and follow-up testing is not always performed as medically recommended for those who test positive for chlamydia, according to a study published online in the American Journal of Obstetrics and Gynecology.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has advanced into drug development a discovery research candidate directed against PCSK9 (proprotein convertase subtilisin/kexin type 9), an important new target for the treatment of high cholesterol. Using its proprietary Locked Nucleic Acid (LNA) Drug Platform and Drug Discovery Engine, Santaris Pharma A/S identified and advanced the new drug, SPC5001, in just 18 months.
Healthcare Trust of America, Inc. announced today that it had closed approximately $156 million of acquisitions in the fourth quarter of 2013. The fourth quarter acquisitions were highlighted by the agreement to acquire an eight medical office building portfolio from a regional developer in Florida for $141 million, $127 million of which closed in December (the "Florida Portfolio").
Many people who survive a heart attack find themselves back in the hospital with a failing heart just years later. And the outcome often is unfavorable, owing to limited treatment options. But scientists at Temple University School of Medicine's Cardiovascular Research Center recently found hope in an unlikely source - stem cells in cortical, or compact, bone.
By analyzing the molecular details of how artificially created drug-resistant flu strains manage to survive treatment, St. Jude Children's Research Hospital scientists have developed insights to guide development of powerful new anti-influenza drugs. These compounds will target a viral enzyme critical to the virus' proliferation in the body.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Robert G Durrans, MD 501 E 770 N, Orem, UT 84097-4102 Ph: (801) 724-9840 | Dr Robert G Durrans, MD 501 E 770 N, Orem, UT 84097-4102 Ph: (801) 724-9840 |
News Archive
Many women are not screened for chlamydia and gonorrhea infection during their pregnancy, and follow-up testing is not always performed as medically recommended for those who test positive for chlamydia, according to a study published online in the American Journal of Obstetrics and Gynecology.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has advanced into drug development a discovery research candidate directed against PCSK9 (proprotein convertase subtilisin/kexin type 9), an important new target for the treatment of high cholesterol. Using its proprietary Locked Nucleic Acid (LNA) Drug Platform and Drug Discovery Engine, Santaris Pharma A/S identified and advanced the new drug, SPC5001, in just 18 months.
Healthcare Trust of America, Inc. announced today that it had closed approximately $156 million of acquisitions in the fourth quarter of 2013. The fourth quarter acquisitions were highlighted by the agreement to acquire an eight medical office building portfolio from a regional developer in Florida for $141 million, $127 million of which closed in December (the "Florida Portfolio").
Many people who survive a heart attack find themselves back in the hospital with a failing heart just years later. And the outcome often is unfavorable, owing to limited treatment options. But scientists at Temple University School of Medicine's Cardiovascular Research Center recently found hope in an unlikely source - stem cells in cortical, or compact, bone.
By analyzing the molecular details of how artificially created drug-resistant flu strains manage to survive treatment, St. Jude Children's Research Hospital scientists have developed insights to guide development of powerful new anti-influenza drugs. These compounds will target a viral enzyme critical to the virus' proliferation in the body.
› Verified 6 days ago
Abraham R Tomco, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 W 800 N, Suite 220, Orem, UT 84057 Phone: 801-354-8205 Fax: 801-354-8206 | |
Darrell R Stacey, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 505 W 400 N, Orem, UT 84057 Phone: 801-714-3450 | |
Joseph C Bingham, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 505 W 400 N, Orem, UT 84057 Phone: 801-714-3450 | |
Randy L Rogers, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 505 W 400 N, Orem, UT 84057 Phone: 801-714-3450 | |
Emily Elizabeth Robbins, APRN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 W 800 N Ste 220, Orem, UT 84057 Phone: 801-354-8205 Fax: 801-354-8206 | |
Andrew Chilberg Judd, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1975 N State St, Orem, UT 84057 Phone: 801-714-5500 | |
Dr. Jennifer Sariah Gilbert, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1975 N State St, Orem, UT 84057 Phone: 801-714-5000 |